Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer Cells
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
5
Page:
449-463
Author(s):
Ilka Wittig and Bernd Groner
Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
815-827
Author(s):
Cezary Marcinkiewicz
Integrins: Regulators of Tissue Function and Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
881-891
Author(s):
Erik H.J. Danen
Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
85-102
Author(s):
Chung Fai Wong, Alexander Guminski, Nicholas A. Saunders and Andrew J. Burgess
Induction of Apoptosis by Curcumin and Its Implications for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
117-129
Author(s):
D. Karunagaran, R. Rashmi and T. R. Santhosh Kumar
Saccharomyces Cerevisiae as a Genetic Model in Anticancer Therapy
Journal:
Current Pharmacogenomics
Volume:
3
Page:
1-7
Author(s):
J. E. Kurtz, P. Dufour, J. P. Bergerat and F. Exinger
The Genetic Regulation of ADPRT/PARP-1 in Aging and Cancer Susceptibility
Journal:
Current Pharmacogenomics
Volume:
3
Page:
9-19
Author(s):
Kristin L. Lockett, Isaac V. Snowhite and Jennifer J. Hu
Gene Therapy in Plastic and Reconstructive Surgery
Journal:
Current Gene Therapy
Volume:
5
Page:
81-99
Author(s):
S. Roman, R. Lindeman, G. O'Toole and M. D. Poole
Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting
Journal:
Current Gene Therapy
Volume:
5
Page:
133-142
Author(s):
William Jia and Qun Zhou
Subject Index to Volume 4
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
73-84
Author(s):
Bentham Science Publishers